Literature DB >> 8638648

Cardiovascular function during rest and exercise in patients with sickle-cell anemia and coexisting alpha thalassemia-2.

D S Braden1, W Covitz, P F Milner.   

Abstract

Cardiac function was measured at rest and during exercise in 9 patients with sickle-cell anemia (SS) and coexisting homozygous alpha thalassemia-2 (alpha thal-2). Results were compared with 18 sickle cell patients with normal alpha globin genes, who were matched to the study group by age, gender, and size, and to published normal values. SS alpha thal-2 patients were less anemic: 9.9 +/- 1.0 vs 8.2 +/- 1.2 gm/dl for SS alone (P<.05). Left ventricular dimensions were normal in SS alpha thal-2 (4.9 +/- 0.7 cm), but increased in SS (5.4 +/- 0.7, cm P=.05) (normal range, 3.7-5.6 cm). Left ventricular wall thickness was, however, dramatically increased in the SS alpha thal-2 patients (free wall, 1.8 +/- 0.6 cm; septum, 1.6 +/- 0.4 cm), though SS controls had normal wall thickness (free wall, 1.0 +/- 0.2 cm; septum, 1.0 +/- 0.2 cm, P<.001) (normal range, 0.6-1.1 cm). At rest, Doppler indices of systolic function were not significantly different between sickle groups and normal values. SS alpha thal-2 patients did have abnormal diastolic filling at rest, as evidenced by a reduced ratio of early/late diastolic filling, 1.4 +/- 0.3 vs. 2.0 +/- 0.5 for SS controls (P<.01), and 1.8 +/- 0.4 for normals. An analysis of covariance suggested that this abnormality persisted after taking into account the previously demonstrated hypertrophy. During exercise, SS alpha thal-2 patients had higher heart rates and blood pressures than SS controls in spite of performing the same or less work. This resulted in a higher double product (an estimate of oxygen consumption) in SS alpha thal-2 patients (37,470 +/- 2,310 mm Hg-BPM) than in SS controls (33,310 +/- 1,490 mm Hg-BPM, P<.01). Work capacity, peak heart rate, and blood pressure were all abnormally decreased in both sickle-cell groups when compared to normal. Cardiac abnormalities noted at rest and during exercise in SS alpha thal-2 patients suggest a role of microvascular occlusion and a protective effect of decreased hemoglobin.

Entities:  

Mesh:

Year:  1996        PMID: 8638648     DOI: 10.1002/(SICI)1096-8652(199606)52:2<96::AID-AJH5>3.0.CO;2-0

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  6 in total

1.  Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease.

Authors:  Vandana Sachdev; Roberto F Machado; Yukitaka Shizukuda; Yesoda N Rao; Stanislav Sidenko; Inez Ernst; Marilyn St Peter; Wynona A Coles; Douglas R Rosing; William C Blackwelder; Oswaldo Castro; Gregory J Kato; Mark T Gladwin
Journal:  J Am Coll Cardiol       Date:  2007-01-16       Impact factor: 24.094

2.  Systolic and diastolic function in middle aged patients with sickle beta thalassaemia. An echocardiographic study.

Authors:  I Moyssakis; R Tzanetea; P Tsaftaridis; I Rombos; D P Papadopoulos; V Kalotychou; A Aessopos
Journal:  Postgrad Med J       Date:  2005-11       Impact factor: 2.401

3.  Alpha thalassemia among sickle cell anaemia patients in Kampala, Uganda.

Authors:  Irene Lubega; Christopher M Ndugwa; Edison A Mworozi; James K Tumwine
Journal:  Afr Health Sci       Date:  2015-06       Impact factor: 0.927

4.  Longitudinal differences in aerobic capacity between children with sickle cell anemia and matched controls.

Authors:  Andrew M Watson; Robert I Liem; Zengqi Lu; Ben Saville; Sari Acra; Sadhna Shankar; Maciej Buchowski
Journal:  Pediatr Blood Cancer       Date:  2014-12-31       Impact factor: 3.167

5.  The Effects of Hydroxyurea Therapy on the Six-Minute Walk Distance in Patients with Adult Sickle Cell Anemia: An Echocardiographic Study.

Authors:  Taysir Garadah; Fatema Mandeel; Ahmed Jaradat; Khalid Bin Thani
Journal:  J Blood Med       Date:  2019-12-27

Review 6.  Safety of maximal cardiopulmonary exercise testing in individuals with sickle cell disease: a systematic review.

Authors:  Kellsey N Smith; Tracy Baynard; Peter S Fischbach; Jane S Hankins; Lewis L Hsu; Peggy M Murphy; Kiri K Ness; Shlomit Radom-Aizik; Amy Tang; Robert I Liem
Journal:  Br J Sports Med       Date:  2021-07-20       Impact factor: 18.473

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.